1 – 40 of 40
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Targeting Nutrient Transporters in Acute Myeloid Leukemia
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
(
- Contribution to journal › Article
- 2023
-
Mark
The International Consensus Classification of acute myeloid leukemia
(
- Contribution to journal › Scientific review
-
Mark
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
CRISPR Screens Identify Candidate Therapeutic Targets in Leukemia
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
(
- Contribution to journal › Article
-
Mark
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
(
- Contribution to journal › Article
-
Mark
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia
(
- Contribution to journal › Article
-
Mark
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
(
- Contribution to journal › Article
- 2021
-
Mark
Potential immunoregulatory role of T and dendritic cells in cancer : Investigations based on transcriptional analysis
2021)(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
(
- Contribution to journal › Article
- 2019
-
Mark
Measurable residual disease testing for personalized treatment of acute myeloid leukemia
(
- Contribution to journal › Scientific review
-
Mark
Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML
(
- Contribution to journal › Article
-
Mark
Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML
(
- Contribution to journal › Article
-
Mark
The role of SRC family kinases in FLT3 signaling
(
- Contribution to journal › Scientific review
- 2018
-
Mark
DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and −KTS isoforms—From initial observations to recent global genomic analyses
(
- Contribution to journal › Scientific review
-
Mark
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
(
- Contribution to journal › Article
-
Mark
Identification of intrinsic regulators in normal and malignant human hematopoiesis. An RNA-interference approach.
(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells
(
- Contribution to journal › Article
-
Mark
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
(
- Contribution to journal › Article
-
Mark
Bioinformatic approaches to gene expression in leukemia. Networks and deconvolution
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
(
- Contribution to journal › Article
- 2016
-
Mark
FLT3 and KIT in acute myeloid leukemia. Translational studies on oncogenic signaling from receptor tyrosine kinases. : Translational studies on oncogenic signaling from receptor tyrosine kinases
2016)(
- Thesis › Doctoral thesis (compilation)
- 2015
-
Mark
Acute lymphoblastic leukemia
2015) p.198-251(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2014
-
Mark
Molecular Mechanisms of the DEK Protein in Leukemia
(
- Thesis › Doctoral thesis (compilation)
- 2013
-
Mark
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
(
- Contribution to journal › Article
-
Mark
Deregulation of protein phosphatase expression in acute myeloid leukemia
(
- Contribution to journal › Article
- 2012
-
Mark
Remission maintenance in acute myeloid leukemia: impact of functional histamine H-2 receptors expressed by leukemic cells
(
- Contribution to journal › Article
- 2011
-
Mark
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
(
- Contribution to journal › Article
-
Mark
Gene expression profiling in MDS and AML: potential and future avenues.
(
- Contribution to journal › Article
- 2010
-
Mark
FLT3 receptor in normal and malignant hematopoiesis
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes.
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
(
- Contribution to journal › Article
-
Mark
A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42
(
- Contribution to journal › Article
-
Mark
Spontaneous remission of "aleukemic" skin chloroma
(
- Contribution to journal › Article
- 2005
-
Mark
Gene Expression Studies of Hematologic Malignacies
2005)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
Boxer's nose deformity as a complication in the course of acute myeloid leukaemia
(
- Contribution to journal › Article
- 2001
-
Mark
Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose-response relations
2001) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 25(10). p.865-872(
- Contribution to journal › Article
-
Mark
Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies
(
- Contribution to journal › Article
- 1986
-
Mark
Differentiation of myeloid leukemic cells in vitro demonstrated by microcalorimetry : Stimulation of leukemic and remission cells by IgG-binding Fc receptors
(
- Contribution to journal › Article